Cianna gets $9m in debut financing round
This article was originally published in Clinica
Aliso Viejo, California-based Cianna Medical has closed a $9m series A funding to expand commercialisation of its Savi breast brachytherapy applicator. Participants in the financing were Fog City Fund and Windamere Venture Partners - both were initial investors in BioLucent from which Cianni was spun out - and several private individuals. Cianni was created when BioLucent was acquired by Hologic in June 2007. Its Savi device is designed to deliver more targeted radiation therapy within the breast, thereby reducing the treatment time from 6-7 weeks to five days.